Tamping Down Tuberculosis in Russia [Slide Show]

The methods for fighting the multidrug resistant TB epidemic in Russia

Join Our Community of Science Lovers!

On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.

View the Treating TB in Russia Slide Show

Tuberculosis (TB) is back in a big way in a big country. The economic collapse that followed the end of communism in Russia in the early 1990s has given rise to a TB epidemic in vast regions of the continent-size country. Researchers say that squalid living conditions, skyrocketing prison populations and rampant drug and alcohol use, coupled with the decline of social services, led to this spike in TB cases.

One hard-hit area is the Tomsk Oblast, or province. This Poland-size area reports that TB infection rates in recent years have declined slightly, to 102.7 new cases annually per 100,000 people. (Comparatively, the U.S. has only about four cases per 100,000 people yearly.)

More alarmingly, some multidrug resistant (MDR) strains of TB have popped up as well. These cases can require treatment lasting two years and involving six to eight different drugs, some of which must be administered daily. In parts of Siberia, where Tomsk is located, this hard-to-treat variety appears in more than 15 percent of the diagnosed patients.

In this slide show, reporter Merrill Goozner documents what he saw during his investigation of the TB epidemic in Russia. Read his articles chronicling the outbreak in ScientificAmerican.com’s In-Depth Report on Tuberculosis in Siberia, including coverage of the community-based fight against the disease and how close-quartered prison populations have incubated the bacteria.

View the Treating TB in Russia Slide Show

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American